Sleep medicine is a relatively recent clinical specialty, yet obstructive sleep apnea (OSA) – the most prevalent sleep disorder – has long been one of the most vexing clinical challenges facing the medical device industry. The science of sleep medicine has grown exponentially over the last 30 years, producing groundbreaking research revealing the extent to which sleep disorders have a significant impact on a multitude of serious cardiovascular diseases and metabolic disorders. The state of sleep therapy, however, has remained largely stagnant. The most effective therapy continues to be what it was in 1981 when CPAP (continuous positive airway pressure) was invented. Unfortunately, CPAP remains almost as unpopular with patients today as it was then, mainly because it requires patients to wear cumbersome, uncomfortable facial masks while sleeping.
As a result, while the OSA population continues to increase as a result of both improvements in diagnosis and the...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on In Vivo for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?
